Weitz Investment Management Inc. purchased a new position in IDEX Corporation (NYSE:IEX – Free Report) in the second quarter, HoldingsChannel reports. The fund purchased 252,400 shares of the industrial products company’s stock, valued at approximately $57,282,000. IDEX makes up approximately 4.0% of Weitz Investment Management Inc.’s portfolio, making the stock its 10th largest holding.
A number of other hedge funds and other institutional investors have also recently made changes to their positions in IEX. Northwestern Mutual Wealth Management Co. purchased a new position in shares of IDEX during the 2nd quarter worth approximately $126,000. Quantbot Technologies LP purchased a new position in shares of IDEX in the 2nd quarter valued at approximately $33,000. Findlay Park Partners LLP bought a new stake in shares of IDEX during the second quarter valued at approximately $72,919,000. Korea Investment CORP purchased a new stake in IDEX in the second quarter worth $7,563,000. Finally, EP Wealth Advisors LLC bought a new position in IDEX in the second quarter worth $542,000. Hedge funds and other institutional investors own 97.96% of the company’s stock.
Analyst Upgrades and Downgrades
A number of brokerages have recently commented on IEX. Stifel Nicolaus boosted their target price on shares of IDEX from $257.00 to $268.00 and gave the company a “buy” rating in a report on Thursday, July 30th. DA Davidson increased their price target on shares of IDEX from $230.00 to $240.00 and gave the stock a “neutral” rating in a research note on Thursday, August 6th. Argus lifted their price target on shares of IDEX from $250.00 to $260.00 and gave the company a “buy” rating in a research report on Thursday, August 6th. Seaport Research Partners reissued a “buy” rating and set a $250.00 price objective on shares of IDEX in a research note on Tuesday, May 5th. Finally, Robert W. Baird set a $257.00 target price on shares of IDEX in a research note on Thursday, April 30th. Eight equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $260.80.
IDEX Stock Up 0.4%
IEX opened at $234.57 on Friday. The company has a quick ratio of 2.15, a current ratio of 3.05 and a debt-to-equity ratio of 0.46. The firm has a 50 day moving average price of $227.88 and a 200-day moving average price of $212.87. IDEX Corporation has a twelve month low of $158.19 and a twelve month high of $243.80. The stock has a market capitalization of $17.29 billion, a price-to-earnings ratio of 33.75, a PEG ratio of 2.21 and a beta of 0.98.
IDEX (NYSE:IEX – Get Free Report) last posted its earnings results on Wednesday, July 29th. The industrial products company reported $2.32 earnings per share for the quarter, beating analysts’ consensus estimates of $2.11 by $0.21. IDEX had a return on equity of 15.69% and a net margin of 14.49%.The company had revenue of $920.60 million for the quarter, compared to the consensus estimate of $905.38 million. During the same quarter in the prior year, the company earned $2.07 earnings per share. IDEX’s revenue was up 6.4% on a year-over-year basis. IDEX has set its FY 2026 guidance at 8.700-8.850 EPS and its Q3 2026 guidance at 2.200-2.250 EPS. Equities research analysts forecast that IDEX Corporation will post 8.82 earnings per share for the current year.
IDEX Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Friday, July 24th. Stockholders of record on Monday, July 6th were paid a $0.73 dividend. The ex-dividend date of this dividend was Monday, July 6th. This represents a $2.92 dividend on an annualized basis and a dividend yield of 1.2%. IDEX’s dividend payout ratio is 42.01%.
Key Headlines Impacting IDEX
Here are the key news stories impacting IDEX this week:
- Positive Sentiment: Analysts raised several forward earnings forecasts. Zacks Research lifted its FY2026 EPS estimate to $8.70 from $8.46, Q3 2026 to $2.20 from $2.17, Q1 2027 to $2.11 from $2.09, FY2027 to $9.21 from $9.20, and FY2028 to $10.45 from $10.27. The upgrades suggest expectations for improving earnings momentum beyond the current year. IDEX analyst estimates
- Positive Sentiment: Longer-term earnings growth remains a key support. The FY2028 forecast implies continued expansion from the approximately $8.70 expected for FY2026, while the company’s latest reported quarter exceeded consensus estimates for both revenue and EPS. IDEX financial information
- Neutral Sentiment: Board changes may increase investor focus on governance and valuation. IDEX announced a board resignation and a governance adjustment. The development does not provide a clear operating-impact signal, but investors may scrutinize leadership, capital allocation, and whether the company’s premium valuation is justified. IDEX board resignation and governance adjustment
- Negative Sentiment: Some estimates were reduced. Zacks cut its Q2 2027 EPS forecast to $2.33 from $2.43 and its Q2 2028 forecast to $2.43 from $2.54. These isolated reductions temper the broader upgrade story and could limit upside if investors view them as signs of uneven demand or execution. IDEX revised earnings estimates
Insider Activity
In related news, CAO Lisa M. Anderson sold 385 shares of the company’s stock in a transaction on Wednesday, August 12th. The shares were sold at an average price of $238.59, for a total value of $91,857.15. Following the completion of the transaction, the chief accounting officer owned 4,327 shares of the company’s stock, valued at approximately $1,032,378.93. This represents a 8.17% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. 0.50% of the stock is currently owned by company insiders.
About IDEX
IDEX Corporation is a diversified industrial manufacturer specializing in the design, production and distribution of highly engineered fluidics systems, measurement technologies and safety solutions. The company’s core offerings include positive-displacement pumps, flow meters, valves, sampling systems and analytical instruments that serve a wide range of end markets such as water treatment, chemical processing, energy, food and beverage, and life sciences. Through its focus on precision engineering and proprietary material science, IDEX delivers products designed for reliability in demanding applications.
Operations at IDEX are organized into three principal segments.
Recommended Stories
- Five stocks we like better than IDEX
- 2 Biotech Stocks Shaping Up for Major Breakouts
- 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs
- 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run
- Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?
Want to see what other hedge funds are holding IEX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for IDEX Corporation (NYSE:IEX – Free Report).
Receive News & Ratings for IDEX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IDEX and related companies with MarketBeat.com's FREE daily email newsletter.
